8-117147014-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173851.3(SLC30A8):c.132G>T(p.Glu44Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00072 in 1,614,070 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173851.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC30A8 | NM_173851.3 | c.132G>T | p.Glu44Asp | missense_variant | 2/8 | ENST00000456015.7 | NP_776250.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC30A8 | ENST00000456015.7 | c.132G>T | p.Glu44Asp | missense_variant | 2/8 | 1 | NM_173851.3 | ENSP00000415011.2 |
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000366 AC: 92AN: 251384Hom.: 0 AF XY: 0.000339 AC XY: 46AN XY: 135856
GnomAD4 exome AF: 0.000753 AC: 1101AN: 1461766Hom.: 1 Cov.: 31 AF XY: 0.000747 AC XY: 543AN XY: 727178
GnomAD4 genome AF: 0.000401 AC: 61AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2024 | The c.132G>T (p.E44D) alteration is located in exon 2 (coding exon 2) of the SLC30A8 gene. This alteration results from a G to T substitution at nucleotide position 132, causing the glutamic acid (E) at amino acid position 44 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at